Is a prolongation of bivalirudin infusion needed in patients with STEMI undergoing percutaneous coronary intervention?
- PMID: 31183989
- DOI: 10.1002/ccd.28368
Is a prolongation of bivalirudin infusion needed in patients with STEMI undergoing percutaneous coronary intervention?
Comment in
-
Postprocedure bivalirudin infusion for primary percutaneous coronary intervention.Catheter Cardiovasc Interv. 2019 Nov 15;94(6):900-901. doi: 10.1002/ccd.28377. Epub 2019 Jun 26. Catheter Cardiovasc Interv. 2019. PMID: 31241248 No abstract available.
Comment on
-
Bivalirudin with a post-procedure infusion versus heparin monotherapy for the prevention of stent thrombosis.Catheter Cardiovasc Interv. 2019 Aug 1;94(2):210-215. doi: 10.1002/ccd.28065. Epub 2019 Jan 13. Catheter Cardiovasc Interv. 2019. PMID: 30636368
References
REFERENCES
-
- Shah R, Latham SB, Porta JM, Naz A, Matin K, Rao SV. Bivalirudin with a post-procedure infusion versus heparin monotherapy for the prevention of stent thrombosis. Catheter Cardiovasc Interv. 2019;94(2):210-215. https://doi.org/10.1002/ccd.28065.
-
- Cavender MA, Sabatine MS. Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials. Lancet. 2014;384(9943):599-606.
-
- Laine M, Lemesle G, Dabry T, et al. Bivalirudin during percutaneous coronary intervention in acute coronary syndromes. Expert Opin Pharmacother. 2019;20(3):295-304.
-
- Gargiulo G, Carrara G, Frigoli E, et al. Post-procedural Bivalirudin infusion at full or low regimen in patients with acute coronary syndrome. J Am Coll Cardiol. 2019;73(7):758-774.
-
- Clemmensen P, Wiberg S, Van't Hof A, et al. Acute stent thrombosis after primary percutaneous coronary intervention: insights from the EUROMAX trial (European ambulance acute coronary syndrome angiography). JACC Cardiovasc Interv. 2015;8(1 Pt B):214-220.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
